Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236467 · ClinicalTrials.gov registry record · NA
Neurohormonal Benefits of Exercise in Fibromyalgia and PTSD
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03236467: Completed NA study, sponsored by VA Office of Research and Development.
NCT03236467 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03236467, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The most recent conflicts are creating a new generation of Veterans, including an increasing number of women Veterans, who present with comorbid PTSD and chronic pain conditions, including Fibromyalgia (FM), from deployment-related physical injuries and exposure to psychological trauma. Health behavior change is important in treating these conditions and proactively preventing long-term negative health sequelae, in order to benefit these Veterans directly and reduce the challenges to our healthcare system. The proposed SPiRE application will use an innovative translational research approach to study whether a progressive -based exercise program will reduce FM pain in patients with PTSD and to elucidate and modify potential PTSD-related deficiencies in neurobiological and psychological responses to exercise to optimize the physical and psychological benefits of exercise for these individuals.
Interventions
- BEHAVIORAL Progressive Exercise Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03236467
The ClinicalTrials.gov registry entry for NCT03236467 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Progressive Exercise Training is the first listed.
NCT03236467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03236467 about?
NCT03236467 is a clinical study titled "Neurohormonal Benefits of Exercise in Fibromyalgia and PTSD". The most recent conflicts are creating a new generation of Veterans, including an increasing number of women Veterans, who present with comorbid PTSD and chronic pain conditions, including Fibromyalgia (FM), from deployment-related physical injuries and exposure to psychological trauma. Health behav...
What is the current status of trial NCT03236467?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-01-01. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT03236467?
The interventions under investigation include: Progressive Exercise Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03236467?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.